Orca Capital AG - 11 Sep 2025 SCHEDULE 13G Report for Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share (SLXN)

Filing Manager: Orca Capital AG
Reporting Manager: Orca Capital AG
Security: Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share
Symbol: SLXN
Shares outstanding: 2,116,935 shares
Disclosed Ownership: 131,250 shares
Ownership: 6.2%
Form type: SCHEDULE 13G
Filing time: 15 Sep 2025, 17:19:57 UTC
Date of event: 11 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Orca Capital AG	6.2%	131,250	131,250	0	/s/ Thomas Konig	Thomas Konig/Director